Published in
Springer, International Journal of Clinical Pharmacy, 2024
DOI: 10.1007/s11096-024-01739-5
Links
Tools
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)
Journal article published in 2024 by
David Young 
,
Clare Harris ,
Sohail Rahmany ,
Inês Iria,
João Gonçalves,
Janet Addison,
Justin Harvey,
Sue Latter ,
Fraser Cummings
,
Clare Harris ,
Sohail Rahmany ,
Inês Iria,
João Gonçalves,
Janet Addison,
Justin Harvey,
Sue Latter ,
Fraser Cummings
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 